Ivan Marazzi News Today

Join us at e-flux on Tuesday, April 30 at 7pm for live performances with Jad Atoui and Robert Aiki Aubrey Lowe.

Sanna Almajedi talks to Jad and Tarek Atoui about their experimental music duo, Through Rust and Dusk. The conversation is followed by an excerpt of their performance at e-flux on September 26, 2022 that incorporated improvisation, custom made instruments, field recordings, and electronic sounds. 

Along with the central nervous system, the immune system may play a fundamental role in Amyotrophic Lateral Sclerosis (ALS), suggesting that bone marrow transplants may be an effective novel treatment for the neurodegenerative disease.

Researchers discovered both immune system and central nervous system dysfunction in animal models and people with ALS4, a genetic, juvenile, and slow-progressing form of ALS.

The immune system may play a fundamental role along with the central nervous system in amyotrophic lateral sclerosis (ALS), also known as "Lou Gehrig's disease," Mount Sinai researchers report.

UTMB researchers receive $11.3 million grant to study immunopathogenesis of Ebola Researchers at the University of Texas Medical Branch at Galveston have been awarded an $11.3 Million, multi-year grant from the National Institute of Allergy and Infectious Diseases to study immunopathogenesis of Ebola, and in particular to determine why cells infected with Ebola develop "immune system paralysis," which inhibits immune response, leads to hyperinflammation, and allows the deadly infection to sprea...

 E-Mail GALVESTON, TEXAS - Researchers at the University of Texas Medical Branch at Galveston have been awarded an $11.3 Million, multi-year grant from the National Institute of Allergy and Infectious Diseases to study immunopathogenesis of Ebola, and in particular to determine why cells infected with Ebola develop "immune system paralysis," which inhibits immune response, leads to hyperinflammation, and allows the deadly infection to spread. The research will be led by Co-Principal Investigat...

Cancer drug may be able to treat inflammation caused by COVID-19 virus: Singapore-US study Toggle share menu Advertisement Cancer drug may be able to treat inflammation caused by COVID-19 virus: Singapore-US study Dr Anand Jeyasekharan with a vial of Topotecan, a cancer drug that could potentially be used in the treatment of COVID-19. (Photo: National University Cancer Institute, Singapore) 07 Apr 2021 09:50PM) Share this content Bookmark SINGAPORE: A widely av...